While the effects of ATRA on ovarian cancer proliferation and apoptosis have been previously investigated [27–31], to date no data has been reported on the effects of ATRA on both annexin A2 and S100A10 expression in serous ovarian cancer cells. The gene discussed is ANXA2; the disease is ovarian serous adenocarcinoma.